Compound Summary
Alloxazine
Compound Information
Alloxazine
Compound Name: | Alloxazine |
Compound CID: | 5372720 |
Synonyms: | Alloxazine Isoalloxazine 490-59-5 Alloxazin benzogpteridine-2,4(1H,3H)-dione More... |
Iupac Name: | 1H-benzo[g]pteridine-2,4-dione |
InChI: | InChI=1S/C10H6N4O2/c15-9-7-8(13-10(16)14-9)12-6-4-2-1-3-5(6)11-7/h1-4H,(H2,12,13,14,15,16) |
InChIKey: | HAUGRYOERYOXHX-UHFFFAOYSA-N |
Canonical Smiles: | C1=CC=C2C(=C1)N=C3C(=N2)NC(=O)NC3=O |
Isomeric Smiles: | C1=CC=C2C(=C1)N=C3C(=N2)NC(=O)NC3=O |
Molecular Weight: | 214.18 |
Molecular Formula: | C10H6N4O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Alloxazine
Molecular Weight: | 214.18 |
Molecular Formula: | C10H6N4O2 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 0 |
Heavy Atom Count: | 16 |
Complexity: | 333 |
Synonyms
Alloxazine
| Alloxazine | Alloxazine |
|---|---|
Alloxazine |
Isoalloxazine |
490-59-5 |
Alloxazin |
benzogpteridine-2,4(1H,3H)-dione |
1H-Benzogpteridine-2,4-dione |
Benzo(g)pteridine-2,4(1H,3H)-dione |
1,2,3,4-Tetrahydrobenzopteridine-2,4-dione |
UNII-880W3VF9YW |
benzogpteridine-2,4(3H,10H)-dione |
CHEMBL68500 |
880W3VF9YW |
CHEBI:37325 |
1H,2H,3H,4H-benzogpteridine-2,4-dione |
Benzogpteridine-2,3H)-dione |
WLN: T C666 BN DMVMV INJ |
1,3-dihydrobenzogpteridine-2,4-dione |
SR-01000075199 |
Alloxazine, 96% |
EINECS 207-714-3 |
NSC 203056 |
Alloxazine;Isoalloxazine |
Lopac-A-242 |
ChemDiv1_028241 |
MixCom6_000433 |
Lopac0_000158 |
Oprea1_036578 |
Oprea1_154895 |
SCHEMBL57289 |
GTPL456 |
MLS001060797 |
BDBM82038 |
CHEBI:37327 |
cid_5372720 |
HMS667D15 |
DTXSID50197656 |
TQP1688 |
HMS1619A05 |
HMS2229H03 |
HMS3260O18 |
10H-benzogpteridine-2,4-dione |
Tox21_500158 |
MFCD00005020 |
NSC_99253 |
NSC203056 |
NSC402746 |
s5427 |
SBB071642 |
STL558392 |
ZINC18804836 |
AKOS000291481 |
AKOS000659671 |
CCG-204253 |
LP00158 |
MCULE-8469415125 |
NSC-203056 |
NSC-402746 |
SDCCGSBI-0050146.P002 |
NCGC00015021-01 |
NCGC00015021-02 |
NCGC00015021-03 |
NCGC00015021-04 |
NCGC00015021-05 |
NCGC00015021-06 |
NCGC00093646-01 |
NCGC00093646-02 |
NCGC00093646-03 |
NCGC00260843-01 |
CAS_490-59-5 |
SMR000282594 |
ST003008 |
DB-051596 |
A-242 |
EU-0100158 |
FT-0718110 |
A16819 |
1-Methyl-3-pyrrolidinecarboxylicacidhydrochloride |
A902050 |
L000103 |
Q408840 |
2,3,4,10-tetrahydro-benzogpteridine-2,4-dione |
SR-01000075199-1 |
SR-01000075199-5 |
BRD-K40213712-001-08-8 |
Z56790788 |
Experimental Data
Alloxazine
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -4.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
Alloxazine
Statistics Data
Alloxazine
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -4.000000000000000 | 1 | 1 |
Statistics Data Visualization
Alloxazine
